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The receptor for interleukin 5 receptor consists of a
cytokine-specific a chain (IL-5Ra), and a signalling b chain,
which is shared with IL-3 and GM-CSF (1,2). These three
cytokines can act in eosinophil development and activation
in vitro, but gene deletion or antibody blocking of IL-5
largely ablates eosinophilic responses in models of allergic
disease or helminth infection. Differential IL-5Ra gene
splicing generates either the membrane-anchored isoform
(TM-IL-5Ra), which associates with the common b chain
to allow IL-5 responsiveness, or a secreted, antagonist
variant (SOL-IL-5Ra) (3). To examine the expression of IL-
5Ra isoforms during human eosinophil development a
system of in vitro eosinophil development from umbilical
cord blood CD34+ progenitor cells grown in IL-3 and IL-5
was used. These cells developed towards the eosinophil
lineage with 84?5%, (range 75–88%, n=10) expressing
major basic protein and showing characteristic eosinophilic
granules by day 14. Competitive RT-PCR showed upregu-
lation of IL-5Ra-TM mRNA relative to that of the soluble
isoform at day 5–7 of culture in IL-3+IL-5. IL-5Ra
expression at the cell surface also increased over time in
culture and a maximal chemokinetic response to IL-5 was
seen by day 7 of culture in IL-3+IL-5. This upregulation ofTM-IL-5Ra was also seen in eosinophils developing in IL-3
or IL-3 and GM-CSF without exogenous IL-5. However,
the switch to TM-IL-5Ra appeared to be IL-5 dependent,
since eosinophil development was blocked by inclusion of
anti-IL-5 (antibody 5A5) in cultures, and IL-5 mRNA was
demonstrated at day 3–5 before TM-IL-5Ra upregulation.
Similar switching from SOL-IL-5Ra to TM-IL-5Ra was
shown in a mingene system in transfected cell lines, and
such switching was seen in response to IL-5, but not IL-3 or
GM-CSF.
These findings suggest that eosinophil development and
lineage expansion is IL-5 dependent, in keeping with the
pronounced eosinophilia seen in IL-5 transgenic mice (4),
and raise the possibility of IL-5 specific signalling (not
shared by IL-3 and GM-CSF, which with IL-5 have a
common receptor b subunit).
Interleukin-9 increases eosinophil
expansion through upregulation of
IL-5Ra
IL-9 has been linked by genetic studies to bronchial
hyperresponsiveness (BHR) in mice and humans, and
transgenic targeting of IL-9 to the airway epithelium in
mice leads to eosinophil infiltration, mast cell hyperplasia
and BHR (5,6). Addition of IL-9 to human umbilical cord
blood CD34+ cells cultured in IL-3 and IL-5 increased cell
yields at day 7 and day 14 in a dose dependent manner,
(mean increase in cell number at day 7, 17%, range 11–
23%, n=5, and 35% at day 14, range 13–57%, n=5). In
addition, flow cytometry showed that addition of IL-9 to
CD34+ progenitors grown in IL-3 and IL-5 increased
expression of IL-5Ra at day 7 and 14, mean increase in
fluorescence for IL-9 added to IL-3+IL-5 at day 7, 47%
n=3, and 80?4% at day 14 n=3. RT-PCR showed that
mRNA for both soluble and membrane associated IL-5Ra
isoforms was induced at days 7 and 14 of culture in IL-9
alone. In addition, IL-9 increased IL-5Ra expression by
mature eosinophils and HL-60 cells developing towards the
eosinophil lineage (not shown). These data suggest that one
mechanism by which IL-9 may contribute to BHR is by
increased IL-5 responsiveness of developing and mature
eosinophils.
CD34+/IL-5Ra mRNA+ cells can be
detected in the airway in asthma
CD34+/IL-5Ra mRNA+ cell numbers detected by simul-
taneous immunohistochemistry for CD34 and in situ
hybridization were increased in bronchial biopsies from
asthmatic subjects when compared to atopic non-asth-
matics and non-atopic control subjects (7). Amongst the
asthmatic subjects there was a significant correlation
between eosinophil numbers and numbers of IL-5Ra
mRNA+ cells in bronchial biopsies (rs ¼ 0  90; P < 0  001)
and between FEV1 and Cd34
+/IL-5Ra mRNA+ cell
numbers for asthmatic subjects (rs ¼ ÿ0  72;P < 0  02)
Fig. 1. CD34+ progenitors switch to TM-IL-5Ra mRNA expression and acquire surface IL-5Ra as they develop into
eosinophils in vitro.
1140 ABSTRACTS(ref). These findings confirm that TM-IL-5Ra expression by
CD34+ can be detected in vivo in asthmatic subjects (8),
and the identification of such cells in the bronchial mucosa
raises the possibility of local airway eosinophil develop-
ment, perhaps driven by local expression of IL-5.
Taken together these data suggest upregulation of IL-
5Ra may be an important check point in eosinophil
infiltration in disease, and thus a potential therapeutic
target. Factors regulating the switch to IL-5Ra expression
remain to be elucidated.
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